Patents by Inventor Timothy Meixsell

Timothy Meixsell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8163529
    Abstract: A nicking endonuclease is described which has an amino acid sequence with at least 70% identity to SEQ ID NO:6 and comprising a mutation at least one of an arginine or glutamic acid corresponding to position 507 and position 546 respectively in SEQ ID NO:6.
    Type: Grant
    Filed: October 18, 2010
    Date of Patent: April 24, 2012
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-Yong Xu, Zhenyu Zhu, Timothy Meixsell
  • Publication number: 20110076720
    Abstract: A nicking endonuclease is described which has an amino acid sequence with at least 70% identity to SEQ ID NO:6 and comprising a mutation at least one of an arginine or gutamic acid corresponding to position 507 and position 546 respectively in SEQ ID NO:6.
    Type: Application
    Filed: October 18, 2010
    Publication date: March 31, 2011
    Inventors: Shuang-Yong Xu, Zhenyu Zhu, Timothy Meixsell
  • Patent number: 7820424
    Abstract: A nicking endonuclease is described which has an amino acid sequence with at least 70% identity to SEQ ID NO:6 and comprising a mutation at least one of an arginine or glutamic acid corresponding to position 507 and position 546 respectively in SEQ ID NO:6.
    Type: Grant
    Filed: July 22, 2005
    Date of Patent: October 26, 2010
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-Yong Xu, Zhenyu Zhu, Timothy Meixsell
  • Publication number: 20080213860
    Abstract: A nicking endonuclease is described which has an amino acid sequence with at least 70% identity to SEQ ID NO:6 and comprising a mutation at least one of an arginine or gutamic acid corresponding to position 507 and position 546 respectively in SEQ ID NO:6.
    Type: Application
    Filed: July 22, 2005
    Publication date: September 4, 2008
    Applicant: NEW ENGLAND BIOLABS, INC.
    Inventors: Shuang-Yong Xu, Zhenyu Zhu, Timothy Meixsell
  • Patent number: 6210945
    Abstract: RsaI, a restriction enzyme from the bacterium Rhodopseudomonas sphaeroides, recognizes the DNA sequence 5′-GTAC-3′. Because RsaI is commercially valuable, we sought to overproduce it by cloning the genes for RsaI and its accompanying, modification, enzyme. The ‘methylase-selection’ method, the customary procedure for cloning restriction and modification genes, was applied to RsaI. The method yielded clones containing the methylase gene (rsaIM), but none containing both the methylase gene and the restriction gene (rsaIR). Inverse-PCR was then used to recover sections of the DNA downstream of rsaIM. These sections were sequenced, and the sequences were joined in silico to reveal the gene organization of the RsaI R-M system.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: April 3, 2001
    Assignee: New England Biolabs, Inc.
    Inventors: Keith D. Lunnen, Richard D. Morgan, Timothy Meixsell, Geoffrey G. Wilson